<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47360/1995-4484-2020-570-576</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-2947</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>РЕВМООРТОПЕДИЯ И РЕАБИЛИТАЦИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORTHOPEDIC RHEUMATOLOGY AND REHABILITATION</subject></subj-group></article-categories><title-group><article-title>Сравнение эффективности субакромиального введения обогащенной тромбоцитами плазмы и гиалуроновой кислоты при хронической боли в области плеча, вызванной поражением сухожилий мышц вращающей манжеты плеча, по данным 6-месячного открытого клинического исследования</article-title><trans-title-group xml:lang="en"><trans-title>Comparison of the effectiveness of subacromial administration of platelet-rich plasma and hyaluronic acid in chronic shoulder pain caused by damage to the tendons of the rotator cuff muscles according to a 6-month open clinical study</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нестеренко</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nesterenko</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, д. 34а</p></bio><bio xml:lang="en"><p>Vadim A. Nesterenko</p><p>34A Kashirskoe highway, Moscow, 115522</p></bio><email xlink:type="simple">swimguy91@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1391-0711</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каратеев</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Karateev</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, д. 34а</p></bio><bio xml:lang="en"><p>Andrey E. Karateev</p><p>34A Kashirskoe highway, Moscow, 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макаров</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarov</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, д. 34а</p></bio><bio xml:lang="en"><p>Maxim A. Makarov</p><p>34A Kashirskoe highway, Moscow, 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бялик</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Byalik</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, д. 34а</p></bio><bio xml:lang="en"><p>Evgeniy I. Byalik</p><p>34A Kashirskoe highway, Moscow, 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макаров</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarov</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, д. 34а</p></bio><bio xml:lang="en"><p>Sergey A. Makarov</p><p>34A Kashirskoe highway, Moscow, 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6068-3080</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лила</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Lila</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, д. 34а</p></bio><bio xml:lang="en"><p>Alexander M. Lila</p><p>34A Kashirskoe highway, Moscow, 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>09</day><month>11</month><year>2020</year></pub-date><volume>58</volume><issue>5</issue><fpage>570</fpage><lpage>576</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Нестеренко В.А., Каратеев А.Е., Макаров М.А., Бялик Е.И., Макаров С.А., Лила А.М., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Нестеренко В.А., Каратеев А.Е., Макаров М.А., Бялик Е.И., Макаров С.А., Лила А.М.</copyright-holder><copyright-holder xml:lang="en">Nesterenko V.A., Karateev A.E., Makarov M.A., Byalik E.I., Makarov S.A., Lila A.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/2947">https://rsp.mediar-press.net/rsp/article/view/2947</self-uri><abstract><p>Локальные инъекции обогащенной тромбоцитами плазмы и гиалуроновой кислоты рассматриваются как эффективный метод лечения хронической боли в области плеча, связанной с поражением сухожилий мышц вращающей манжеты плеча.</p><p>Цель исследования – сравнить эффективность и безопасность локальной терапии обогащенной тромбоцитами плазмой и гиалуроновой кислотой у пациентов с хронической болью в области плеча, вызванной поражением сухожилий мышц вращающей манжеты плеча.</p><sec><title>Материал и методы</title><p>Материал и методы. В исследование были включены 100 пациентов (54% женщин и 46% мужчин, средний возраст 51,5±15,1 года) с хронической болью в области плеча (сохраняющейся на протяжении ≥3 мес.), связанной с повреждением и тендинитом надостной, подостной, подлопаточной или малой круглой мышц, подтвержденными данными магнитно-резонансной томографии или ультразвукового исследования. Пациенты были рандомизированы в две группы по 50 человек, в которых было проведено лечение обогащенной тромбоцитами плазмой (три инъекции с интервалом 7 дней) или ГлК (две инъекции с интервалом 7 дней). Инъекции выполнялись под контролем УЗИ в субакромиальную сумку. Результаты исследования оценивались по динамике интенсивности боли (по визуальной аналоговой шкале, 100 мм) и функциональных нарушений (индексы ASES и CSS) через 1, 3 и 6 мес.</p></sec><sec><title>Результаты</title><p>Результаты. На фоне использования обогащенной тромбоцитами плазмы и гиалуроновой кислоты отмечалось существенное улучшение состояния пациентов, при этом оба препарата показали примерно одинаковую эффективность. Выраженность боли по визуальной аналоговой шкале через 6 месяцев снизилась соответственно с 56,8±15,5 и 57,6±17,8 мм до 31,8±27,8 и 30,2±26,3 мм, ASES – c 55,8±15,9 и 53,6±14,7 до 74,6± 22,4 и 77,3± 22,4, CSS – c 59,2±14,4 и 47,8±16,9 до 69,9±17,3 и 65,6±19,2. Динамика всех указанных показателей по сравнению с исходным уровнем была статистически значимой (p&lt;0,001). Число больных с умеренной/слабой болью (&lt;40 мм визуальной аналоговой шкалы) через 6 мес. после введения обогащенной тромбоцитами плазмы и гиалуроновой кислоты составило 48 и 60%, нуждающихся в регулярном приеме нестероидных противовоспалительных препаратов – 30 и 28% соответственно. По всем параметрам различие эффективности обогащенной тромбоцитами плазмы и гиалуроновой кислоты не было статистически значимым (p&gt;0,05). Эффективность обогащенной тромбоцитами плазмы и гиалуроновой кислоты (по динамике боли, ASES и CSS) была существенно выше у лиц моложе 45 лет в сравнении с пациентами более старшего возраста. Переносимость терапии была хорошей – после введения обогащенной тромбоцитами плазмы у 40% больных отмечалось кратковременное (3–4 дня) усиление боли, которое не требовало применения дополнительных анальгетиков или прерывания лечения. Серьезные неблагоприятные реакции при использовании обогащенной тромбоцитами плазмы и гиалуроновой кислоты не отмечались.</p></sec><sec><title>Заключение</title><p>Заключение. Обогащенная тромбоцитами плазма и гиалуроновая кислота эффективны и безопасны при лечении хронической боли в области плеча, связанной с поражением сухожилий мышц вращающей манжеты плеча. Динамика интенсивности боли и функционального статуса после применения этих препаратов не различалась. Лечение обогащенной тромбоцитами плазмой и гиалуроновой кислотой более эффективно у лиц моложе 45 лет.</p></sec></abstract><trans-abstract xml:lang="en"><p>Local injections of platelet-rich plasma (PRP) and hyaluronic acid (HLA) are considered an effective method for treating chronic shoulder pain (CSP) associated with damage to the tendons of the rotator cuff muscles (RCM).</p><p>The aim of the study is to compare the effectiveness and safety of local therapy of PRP and HLA in patients with CSP caused by damage to the tendons of the RCM muscles.</p><sec><title>Materials and methods</title><p>Materials and methods. The study included 100 patients (54% women and 46% men, average age 51.5±15.1 years) with CSP (persisting for ≥3 months) associated with damage and tendinitis of the supraspinatus, subacute, scapular or small round muscle, confirmed by magnetic resonance imaging or ultrasound (ultrasound). The patients were randomized into two groups of 50 people who were treated with PRP (three injections at 7-day intervals) or HLA (two injections at 7-day intervals). The injections were performed under ultrasound control in the subacromial SAC. The results of the study were evaluated by the dynamics of pain intensity (on a visual analog scale, up to 100 mm) and functional disorders (ASES and CSS indices) after 1, 3 and 6 months.</p></sec><sec><title>Results</title><p>Results. Against the background of the use of PRP and HLA, there was a significant improvement in the condition of patients, while both drugs showed approximately the same effectiveness. The severity of VAS pain decreased from 56.8±15, respectively, after 6 months.5 and 57.6±17.8 mm to 31.8±27.8 and 30.2±26.3 mm, ASES-c 55.8±15.9 and 53.6±14.7 to 74.6±22.4 and 77.3± 22.4, CSS-c 59.2±14.4 and 47.8±16.9 to 69.9±17.3 and 65.6±19.2. the Dynamics of all these indicators in comparison with the baseline level was statistically significant (p&lt;0.001). Number of patients with moderate / mild pain (&lt;40 mm VAS) after 6 months. after the introduction of PRP and HLA was 48% and 60%, requiring regular NSAID intake 30% and 28%, respectively. In all parameters, the difference in the effectiveness of PRP and HLC was not statistically significant (p&gt;0.05). The effectiveness of PRP and HLA (in terms of pain dynamics, ASES, and CSS) was significantly higher in individuals younger than 45 years, compared to older patients. The tolerability of therapy was good – after the introduction of PRP, 40% of patients had a short-term (3–4 days) increase in pain, which did not require the use of additional analgesics or interruption of treatment. No serious adverse reactions were observed when using PRP and HLA.</p></sec><sec><title>Conclusion</title><p>Conclusion. OTP and GLA are effective and safe in the treatment of CSP associated with damage to the tendons of the RCM muscles. The dynamics of pain intensity and functional status after the use of these drugs did not differ. Treatment of PRP and HLA is more effective in people younger than 45 years.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая боль в области плеча</kwd><kwd>синдром сдавления ротаторов плеча</kwd><kwd>обогащенная тромбоцитами плазма</kwd><kwd>гиалуроновая кислота</kwd><kwd>субакромиальное введение</kwd><kwd>эффективность</kwd><kwd>безопасность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic shoulder pain</kwd><kwd>shoulder rotator compression syndrome</kwd><kwd>platelet-rich plasma</kwd><kwd>hyaluronic acid</kwd><kwd>subacromial administration</kwd><kwd>efficacy</kwd><kwd>safety</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Micallef J., Pandya J., Low A.K. Management of rotator cuff tears in the elderly population. Maturitas. 2019;123:9–14. DOI: 10.1016/j.maturitas.2019.01.0</mixed-citation><mixed-citation xml:lang="en">Micallef J., Pandya J., Low A.K. Management of rotator cuff tears in the elderly population. Maturitas. 2019;123:9–14. DOI: 10.1016/j.maturitas.2019.01.0</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ramme A.J., Robbins C.B., Patel K.A., Carpenter J.E., Bedi A., Gagnier J.J., Miller B.S. Surgical Versus Nonsurgical Management of Rotator Cuff Tears: A Matched-Pair Analysis. J Bone Joint Surg Am. 2019;101(19):1775–1782. DOI: 10.2106/JBJS.18.01473</mixed-citation><mixed-citation xml:lang="en">Ramme A.J., Robbins C.B., Patel K.A., Carpenter J.E., Bedi A., Gagnier J.J., Miller B.S. Surgical Versus Nonsurgical Management of Rotator Cuff Tears: A Matched-Pair Analysis. J Bone Joint Surg Am. 2019;101(19):1775–1782. DOI: 10.2106/JBJS.18.01473</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Page M.J., O’Connor D.A., Malek M., Haas R., Beaton D., Huang H., et al. Patients’ experience of shoulder disorders: a systematic review of qualitative studies for the OMERACT Shoulder Core Domain Set. Rheumatology (Oxford). 2019. PII: kez046. DOI: 10.1093/rheumatology/kez046</mixed-citation><mixed-citation xml:lang="en">Page M.J., O’Connor D.A., Malek M., Haas R., Beaton D., Huang H., et al. Patients’ experience of shoulder disorders: a systematic review of qualitative studies for the OMERACT Shoulder Core Domain Set. Rheumatology (Oxford). 2019. PII: kez046. DOI: 10.1093/rheumatology/kez046</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Luime J.J., Koes B.W., Hendriksen I.J., Burdorf A., Verhagen A.P., Miedema H.S., Verhaar J.A. Prevalence and incidence of shoulder pain in the general population; a systematic review. Scand J Rheumatol. 2004;33(2):73–81. DOI: 10.1080/03009740310004667</mixed-citation><mixed-citation xml:lang="en">Luime J.J., Koes B.W., Hendriksen I.J., Burdorf A., Verhagen A.P., Miedema H.S., Verhaar J.A. Prevalence and incidence of shoulder pain in the general population; a systematic review. Scand J Rheumatol. 2004;33(2):73–81. DOI: 10.1080/03009740310004667</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dougados M., Le Henanff A., Logeart I., Ravaud P. Short-term efficacy of rofecoxib and diclofenac in acute shoulder pain: a placebo-controlled randomized trial. PLoS Clin Trials. 2007;2(3):e9. DOI: 10.1371/journal.pctr.0020009</mixed-citation><mixed-citation xml:lang="en">Dougados M., Le Henanff A., Logeart I., Ravaud P. Short-term efficacy of rofecoxib and diclofenac in acute shoulder pain: a placebo-controlled randomized trial. PLoS Clin Trials. 2007;2(3):e9. DOI: 10.1371/journal.pctr.0020009</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Greving K., Dorrestijn O., Winters J.C., Groenhof F., van der Meer K., Stevens M., Diercks R.L. Incidence, prevalence, and consultation rates of shoulder complaints in general practice. Scand J Rheumatol. 2012;41(2):150–155. DOI: 10.3109/03009742.2011.605390</mixed-citation><mixed-citation xml:lang="en">Greving K., Dorrestijn O., Winters J.C., Groenhof F., van der Meer K., Stevens M., Diercks R.L. Incidence, prevalence, and consultation rates of shoulder complaints in general practice. Scand J Rheumatol. 2012;41(2):150–155. DOI: 10.3109/03009742.2011.605390</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Каратеев А.Е., Лила А.М., Загородний Н.В., Погожева Е.Ю. Поражение околосуставных мягких тканей в реальной клинической практике: частота, характер, эффективность нестероидных противовоспалительных препаратов. Терапевтический архив. 2019;91(12):21–28. DOI: 10.26442/00403660.2019.12.000377</mixed-citation><mixed-citation xml:lang="en">Karateev A.E., Lila A.M., Zagorodny N.V., Pogozheva E. Yu. Lesion of periarticular soft tissues in real clinical practice: frequency, nature, effectiveness of non-steroidal anti-inflammatory drugs. Terapevticheskiy arkhiv = Therapeutic archive. 2019;91(12):21–28. (In Russ.) DOI: 10.26442/00403660.2019.12.000377</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chang R.F., Lee C.C., Lo C.M. Quantitative diagnosis of rotator cuff tears based on sonographic pattern recognition. PLoS One. 2019;14(2):e0212741. DOI: 10.1371/journal.pone.0212741</mixed-citation><mixed-citation xml:lang="en">Chang R.F., Lee C.C., Lo C.M. Quantitative diagnosis of rotator cuff tears based on sonographic pattern recognition. PLoS One. 2019;14(2):e0212741. DOI: 10.1371/journal.pone.0212741</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lewis J. Rotator cuff related shoulder pain: Assessment, management and uncertainties. Man Ther. 2016;23:57–68. DOI: 10.1016/j.math.2016.03.009</mixed-citation><mixed-citation xml:lang="en">Lewis J. Rotator cuff related shoulder pain: Assessment, management and uncertainties. Man Ther. 2016;23:57–68. DOI: 10.1016/j.math.2016.03.009</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lin K.M., Wang D., Dines J.S. Injection Therapies for Rotator Cuff Disease. Orthop Clin North Am. 2018;49(2):231–239. DOI: 10.1016/j.ocl.2017.11.010</mixed-citation><mixed-citation xml:lang="en">Lin K.M., Wang D., Dines J.S. Injection Therapies for Rotator Cuff Disease. Orthop Clin North Am. 2018;49(2):231–239. DOI: 10.1016/j.ocl.2017.11.010</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Moraes V.Y., Lenza M., Tamaoki M.J., Faloppa F., Belloti J.C. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev. 2014;(4):CD010071. DOI: 10.1002/14651858.CD010071.pub3</mixed-citation><mixed-citation xml:lang="en">Moraes V.Y., Lenza M., Tamaoki M.J., Faloppa F., Belloti J.C. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev. 2014;(4):CD010071. DOI: 10.1002/14651858.CD010071.pub3</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gallorini M., Berardi A.C., Berardocco M., Gissi C., Maffulli N., Cataldi A., Oliva F. Hyaluronic acid increases tendon derived cell viability and proliferation in vitro: comparative study of two different hyaluronic acid preparations by molecular weight. Muscles Ligaments Tendons J. 2017;7(2):208–214. DOI: 10.11138/mltj/2017.7.2.208</mixed-citation><mixed-citation xml:lang="en">Gallorini M., Berardi A.C., Berardocco M., Gissi C., Maffulli N., Cataldi A., Oliva F. Hyaluronic acid increases tendon derived cell viability and proliferation in vitro: comparative study of two different hyaluronic acid preparations by molecular weight. Muscles Ligaments Tendons J. 2017;7(2):208–214. DOI: 10.11138/mltj/2017.7.2.208</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Osti L., Berardocco M., di Giacomo V., Di Bernardo G., Oliva F., Berardi A.C. Hyaluronic acid increases tendon derived cell viability and collagen type I expression in vitro: Comparative study of four different Hyaluronic acid preparations by molecular weight. BMC Musculoskelet Disord. 2015;16:284. DOI: 10.1186/s12891-015-0735-7</mixed-citation><mixed-citation xml:lang="en">Osti L., Berardocco M., di Giacomo V., Di Bernardo G., Oliva F., Berardi A.C. Hyaluronic acid increases tendon derived cell viability and collagen type I expression in vitro: Comparative study of four different Hyaluronic acid preparations by molecular weight. BMC Musculoskelet Disord. 2015;16:284. DOI: 10.1186/s12891-015-0735-7</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lin M.T., Wei K.C., Wu C.H. Effectiveness of Platelet-Rich Plasma Injection in Rotator Cuff Tendinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diagnostics (Basel). 2020;10(4). PII: E189. DOI: 10.3390/diagnostics10040189</mixed-citation><mixed-citation xml:lang="en">Lin M.T., Wei K.C., Wu C.H. Effectiveness of Platelet-Rich Plasma Injection in Rotator Cuff Tendinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diagnostics (Basel). 2020;10(4). PII: E189. DOI: 10.3390/diagnostics10040189</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Osti L., Buda M., Buono A.D., Osti R., Massari L. Clinical evidence in the treatment of rotator cuff tears with hyaluronic acid. Muscles Ligaments Tendons J. 2016;5(4):270–275. DOI: 10.11138/mltj/2015.5.4.270</mixed-citation><mixed-citation xml:lang="en">Osti L., Buda M., Buono A.D., Osti R., Massari L. Clinical evidence in the treatment of rotator cuff tears with hyaluronic acid. Muscles Ligaments Tendons J. 2016;5(4):270–275. DOI: 10.11138/mltj/2015.5.4.270</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Cai Y.U., Sun Z., Liao B., Song Z., Xiao T., Zhu P. Sodium Hyaluronate and Platelet-Rich Plasma for Partial-Thickness Rotator Cuff Tears. Med Sci Sports Exerc. 2019;51(2):227–233. DOI: 10.1249/MSS.0000000000001781</mixed-citation><mixed-citation xml:lang="en">Cai Y.U., Sun Z., Liao B., Song Z., Xiao T., Zhu P. Sodium Hyaluronate and Platelet-Rich Plasma for Partial-Thickness Rotator Cuff Tears. Med Sci Sports Exerc. 2019;51(2):227–233. DOI: 10.1249/MSS.0000000000001781</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X., Jones I.A., Togashi R., Park C., Vangsness C.T. Jr. Use of Platelet-Rich Plasma for the Improvement of Pain and Function in Rotator Cuff Tears: A Systematic Review and Metaanalysis With Bias Assessment. Am J Sports Med. 2019:363546519881423. DOI: 10.1177/0363546519881423</mixed-citation><mixed-citation xml:lang="en">Chen X., Jones I.A., Togashi R., Park C., Vangsness C.T. Jr. Use of Platelet-Rich Plasma for the Improvement of Pain and Function in Rotator Cuff Tears: A Systematic Review and Metaanalysis With Bias Assessment. Am J Sports Med. 2019:363546519881423. DOI: 10.1177/0363546519881423</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rha D.W., Park G.Y., Kim Y.K., Kim M.T., Lee S.C. Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial. Clin Rehabil. 2013;27(2):113–122. DOI: 10.1177/0269215512448388</mixed-citation><mixed-citation xml:lang="en">Rha D.W., Park G.Y., Kim Y.K., Kim M.T., Lee S.C. Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial. Clin Rehabil. 2013;27(2):113–122. DOI: 10.1177/0269215512448388</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Schwitzguebel A.J., Kolo F.C., Tirefort J., Kourhani A., Nowak A., Gremeaux V., et al. Efficacy of Platelet-Rich Plasma for the Treatment of Interstitial Supraspinatus Tears: A Double-Blinded, Randomized Controlled Trial. Am J Sports Med. 2019;47(8):1885–1892. DOI: 10.1177/0363546519851097</mixed-citation><mixed-citation xml:lang="en">Schwitzguebel A.J., Kolo F.C., Tirefort J., Kourhani A., Nowak A., Gremeaux V., et al. Efficacy of Platelet-Rich Plasma for the Treatment of Interstitial Supraspinatus Tears: A Double-Blinded, Randomized Controlled Trial. Am J Sports Med. 2019;47(8):1885–1892. DOI: 10.1177/0363546519851097</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Y.C., Leong C.P., Tso H.H., Chen M.J., Liaw M.Y., Hsieh H.C., et al. The long-term effects of hyaluronic acid on hemiplegic shoulder pain and injury in stroke patients: A randomized controlled study. Medicine (Baltimore). 2018;97(35):e12078. DOI: 10.1097/MD.0000000000012078</mixed-citation><mixed-citation xml:lang="en">Huang Y.C., Leong C.P., Tso H.H., Chen M.J., Liaw M.Y., Hsieh H.C., et al. The long-term effects of hyaluronic acid on hemiplegic shoulder pain and injury in stroke patients: A randomized controlled study. Medicine (Baltimore). 2018;97(35):e12078. DOI: 10.1097/MD.0000000000012078</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Moghtaderi A., Sajadiyeh S., Khosrawi S., Dehghan F., Bateni V. Effect of subacromial sodium hyaluronate injection on rotator cuff disease: A double-blind placebo-controlled clinical trial. Adv Biomed Res. 2013;2:89. DOI: 10.4103/2277-9175.122517</mixed-citation><mixed-citation xml:lang="en">Moghtaderi A., Sajadiyeh S., Khosrawi S., Dehghan F., Bateni V. Effect of subacromial sodium hyaluronate injection on rotator cuff disease: A double-blind placebo-controlled clinical trial. Adv Biomed Res. 2013;2:89. DOI: 10.4103/2277-9175.122517</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng M., Johnson V.M., Murray M.M. Effects of age and platelet-rich plasma on ACL cell viability and collagen gene expression. J Orthop Res. 2012;30(1):79–85. DOI: 10.1002/jor.21496</mixed-citation><mixed-citation xml:lang="en">Cheng M., Johnson V.M., Murray M.M. Effects of age and platelet-rich plasma on ACL cell viability and collagen gene expression. J Orthop Res. 2012;30(1):79–85. DOI: 10.1002/jor.21496</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Gabusi E., Paolella F., Manferdini C., Gambari L., Schiavinato A., Lisignoli G. Age-independent effects of hyaluronan amide derivative and growth hormone on human osteoarthritic chondrocytes. Connect Tissue Res. 2015;56(6):440–451. DOI: 10.3109/03008207.2015.1047928</mixed-citation><mixed-citation xml:lang="en">Gabusi E., Paolella F., Manferdini C., Gambari L., Schiavinato A., Lisignoli G. Age-independent effects of hyaluronan amide derivative and growth hormone on human osteoarthritic chondrocytes. Connect Tissue Res. 2015;56(6):440–451. DOI: 10.3109/03008207.2015.1047928</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
